Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1Endocrine 1

Conditions

Thyroid Diseases 1Pituitary Neoplasms 1Pituitary Diseases 1Hypothyroidism 1Cancer-related Fatigue 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Has results × Thyrotropin-Releasing Hormone × Clear all
NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
96 enrolled 6 charts
EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

NCT00790296 2017-12-28

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

UConn Health

Phase 2 Terminated
11 enrolled 5 charts
Other

Cancer-related Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡